Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.

@article{Roubenoff1987RemissionOR,
  title={Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.},
  author={Ronenn Roubenoff and Richard M. Jones and Judith E. Karp and Mary Betty Stevens},
  journal={Arthritis and rheumatism},
  year={1987},
  volume={30 10},
  pages={1187-90}
}
We describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia (cytosine arabinoside, daunorubicin, and m-AMSA), even though both illnesses had been refractory to therapy with standard disease-modifying agents. These 2 patients represent the first successful treatment of rheumatoid disease using such an approach.